Search Results 51-60 of 12610 for edward loftus

  1. Faculty and staff - Irritable Bowel Syndrome Lab: Yuri A. Saito-Loftus - Mayo Clinic Research

    View faculty and staff of the Irritable Bowel Syndrome Lab of Yuri A. Saito Loftus, M.D., at Mayo Clinic's campus in Minnesota.

  2. Study to Evaluate Efficacy and Safety of Two Drug Regimens in Subjects with Moderate to Severe Crohn's Disease - Mayo Clinic

    Edward Loftus, M.D.. Closed for enrollment. More information. Publications. Publications are currently not available. Additional contact information. Non-cancer ...

  3. Efficacy and Safety Trial of RPC1063 for Moderate to Severe Crohn's Disease - Mayo Clinic

    Edward Loftus, M.D.. Closed for enrollment. More information. Publications. Publications are currently not available. Additional contact information. Non-cancer ...

  4. A Long-term Active Treatment Study of Mongersen (GED-0301) in Subjects With Crohn's Disease - Mayo Clinic

    Edward Loftus, M.D.. Closed for enrollment. More information. Publications. Publications are currently not available. Additional contact information. Non-cancer ...

  5. Focus Areas - Irritable Bowel Syndrome Lab: Yuri A. Saito-Loftus - Mayo Clinic Research

    Mayo Clinic's Irritable Bowel Syndrome Lab led by Yuri A. Saito Loftus, M.D., studies epidemiology and genetic, environmental and familial contributors to ...

  6. A Study to Evaluate the Safety and Effectiveness of Ustekinumab Induction and Maintenance Therapy in Participants with Moderately to Severely Active Ulcerative Colitis - Mayo Clinic

    Edward Loftus, M.D.. Closed for enrollment. More information. Publications. Publications are currently not available. Additional contact information. Non-cancer ...

  7. A Study to Evaluate the Safety and Efficacy of Ustekinumab Maintenance Therapy in Patients With Moderately to Severely Active Crohn's Disease (IM-UNITI) - Mayo Clinic

    Edward Loftus, M.D.. Closed for enrollment. More information. Publications. Publications are currently not available. Additional contact information. Non-cancer ...

  8. A Study of Efficacy and Safety of Mongersen (GED-0301) for the Treatment of Adult and Adolescent Subjects With Active Crohn's Disease - Mayo Clinic

    Participating Mayo Clinic locations ; Rochester, Minn. Mayo Clinic principal investigator. Edward Loftus, M.D.. Closed for enrollment ...

  9. A Study Comparing the Long Term Safety of Entyvio (Vedolizumab) to Other Biologic Agents in Patients with Ulcerative Colitis or Crohn's Disease - Mayo Clinic

    Participating Mayo Clinic locations ; Rochester, Minn. Mayo Clinic principal investigator. Edward Loftus, M.D.. Closed for enrollment ...

  10. A Study of the Safety and Effectiveness of GS-5745 in Participants with Moderately to Severely Active Crohn's Disease - Mayo Clinic

    Edward Loftus, M.D.. Closed for enrollment. More information. Publications. Publications are currently not available. Additional contact information. Non-cancer ...